Gilead is getting closer to a deal to buy Immunomedics for more than $20 billion – CNBC

Gilead Sciences Inc is nearing a deal to buy biopharmaceutical company Immunomedics Inc for more than $20 billion in a deal that would further expand Gilead’s portfolio of cancer treatments, the Wall… [read more]

Leave a Reply

Your email address will not be published. Required fields are marked *